Investing Profile

Jim Tananbaum

VCInvestorCEOFounder
Founder and CEO at Foresite Capital.
foresitecapital.com/people/ji...San Francisco, California
Photo of Jim Tananbaum, Investor at Foresite Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard Business School Network
422 CONNECTIONS
Massachusetts Institute of Technology Network
177 CONNECTIONS
Yale University Network
126 CONNECTIONS
Harvard Medical School Network
20 CONNECTIONS
Sierra Ventures Network
13 CONNECTIONS
cb
$100K - $5.0M
$1.5M
33
$668M
CompanyStageDateRound SizeTotal Raised
Foresight Diagnostics
Series BJul 2024$33M
Series BApr 2023$59M
$110M
Co-investors: Shahram Seyedin-Noor (Civilization Ventures), Vikram Bajaj (Foresite Capital)
Element Biosciences
Series DJul 2024$280M
Series CJun 2021$280M
$550M
Co-investors: Bryan Roberts (Venrock)
Alumis
Series CMar 2024$260M
Series AMay 2021$70M
$330M
Co-investors: Michael Rome (Foresite Capital), Vikram Bajaj (Foresite Capital), Richard Gaster (venBio)
Genomics
Series CJan 2024$45M
Series UnknownMar 2021$30M
$84M
Co-investors: Stephen Knight (F-Prime Capital Partners)
evonetix
Series BFeb 2023$24M
Series BMar 2020$30M
$66M
Co-investors: Ameena El-Bibany (Artis Ventures (AV)), Vishal Gulati (Molten Ventures), Armen Vidian
DNAnexus
Series HMar 2022$200M
Series GJun 2020$100M
Series FFeb 2019$68M
Series EJan 2018$58M
$460M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Jeff Clavier (Uncork Capital), Manu Kumar (K9 Ventures), Rob Hayes (First Round Capital), Michael Rubin (Northpond Ventures), Nat Goldhaber
ImmPACT Bio
Series BJan 2022$140M
$140M
Co-investors: Yvonne Yamanaka (venBio), Richard Gaster (venBio), Cindy Xiong (Foresite Capital)
XinThera
Series BAug 2021$50M
$50M
Co-investors: Carl Gordon (OrbiMed), Michael Rome (Foresite Capital)
Co-Founder and Chief Executive Officer Theravance (THRX)Present
Co-Founder and Managing Director PVP2 & PVP3 Prospect Venture PartnersPresent
Founder and CEO Foresite Capital ManagementPresent
Partner Sierra Ventures1993 - 1997
Co-Founder and CEO GelTex (acquired by Genzyme for $1.6 B)1991 - 1992
Harvard Business School mba
Harvard Medical School Doctor of Medicine (MD)
Massachusetts Institute of Technology Master of Science (M.S.) HST - information theory
Yale University BS BSEE, Math, computer science